5 min read
FDA to review Moderna's mRNA flu vaccine after reversing rejection
FDA reversed its refusal to review Moderna's mRNA flu vaccine application after the company proposed a revised regulatory pathway. A decision is expected by Aug 2026.
1 article
FDA reversed its refusal to review Moderna's mRNA flu vaccine application after the company proposed a revised regulatory pathway. A decision is expected by Aug 2026.